Interdisciplinary Multimodal Pain Therapy for Chronic Pain in Routine Care: Examining patient-reported and performance-based correlates of treatment outcomes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00036855

Enrollment

300

Registered

2025-05-19

Start date

2024-11-01

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M00-M99

Interventions

Group 1: Waiting period (at least 3 weeks) and then 4 weeks of interdisciplinary multimodal pain therapy in an outpatient clinic. The treatment includes active treatment elements such as exercise ther

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: People with chronic (>3 months) musculoskeletal pain; biopsychosocial etiology of pain

Exclusion criteria

Exclusion criteria: inability to participate actively in treatment (insufficient physical ability to e.g. walk 500m, language skills, motivation), acute organic (e.g. tumor) or psychiatric illness (e.g. psychosis, drug addiction) that requires prior treatment, ongoing pension proceedings

Design outcomes

Primary

Measure	Time frame
The primary dependent variable is pain intensity. Survey by self-report at T0 (at least 3 months before treatment), T3 (6 months after the end of treatment) using the von Korff pain questionnaire (Von Korff et al., (1992). Pain intensity subscale.	—

Secondary

Measure	Time frame
Pain-related impairment (von Korff, von Korff et al., 1992) at T0, T3. Impairment subscale. Pain severity (von Korff, von Korff et al., 1992) at T0, T3. Health-related quality of life (VR12, Buchholz, Feng, Buchholz, Kazis, & Kohlmann, 2021) at T0, T3. Mental health (DASS, Nilges & Essau, 2021) at T0, T3. Well-Being (FW7, Basler 1999) at T0, T3. Balance and body stability (obj. assessed by S3-Check, Raschner, Lembert, Platzer, Patterson, Hilden, & Lutz, 2008) at T1 (beginning of treatment), T2 (end of treatment). Strength and endurance (obj. assessed by prone bridge test, Schellenberg et al., 2007) at T1, T2. Physical fitness (obj. assessed by stair climb test, Tan et al., 2004) at T1, T2.	—

Measure

Time frame

Pain-related impairment (von Korff, von Korff et al., 1992) at T0, T3. Impairment subscale. Pain severity (von Korff, von Korff et al., 1992) at T0, T3. Health-related quality of life (VR12, Buchholz, Feng, Buchholz, Kazis, & Kohlmann, 2021) at T0, T3. Mental health (DASS, Nilges & Essau, 2021) at T0, T3. Well-Being (FW7, Basler 1999) at T0, T3. Balance and body stability (obj. assessed by S3-Check, Raschner, Lembert, Platzer, Patterson, Hilden, & Lutz, 2008) at T1 (beginning of treatment), T2 (end of treatment). Strength and endurance (obj. assessed by prone bridge test, Schellenberg et al., 2007) at T1, T2. Physical fitness (obj. assessed by stair climb test, Tan et al., 2004) at T1, T2.

—

Countries

Germany

Contacts

Public ContactLena Fleig

Medical School Berlin

lena.fleig@medicalschool-berlin.de+49 30 - 7668375816

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026